Journal Reviews

Orbit journal cover

Therapeutic options for advanced cutaneous basal (BCC) and squamous cell carcinomas (SCC)

9 August 2023 | | Oculoplastics, Orbit | Basal cell carcinoma, hedgehog inhibitors, imiquimod, immunotherapy, squamous cell carcinoma

This article discusses the use of topical and systemic therapy in the management of advanced periocular tumours. It focuses on those that have gained United States Food and Drug Administration approval; namely imiquimod, vismodegib, sonidegib, pembrolizumab and cemiplimab. Imiquimod is...